Abstract:Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPLs) that predispose individuals to thrombotic events and pregnancy-related complications. APS can occur as a primary condition or in association with other autoimmune diseases, most commonly systemic lupus erythematosus (SLE). Catastrophic APS (CAPS) is a rare, severe variant of APS, marked by rapid-onset, widespread thrombosis leading to multi-organ failure, often triggered by infections, surgical procedures, or cessation of anticoagulation therapy. Both APS and CAPS present significant clinical challenges due to their potential for severe morbidity and mortality. This comprehensive review aims to provide a detailed overview of the pathogenesis, clinical features, diagnostic criteria, and management strategies for APS and CAPS. The review highlights the immunological mechanisms underlying APS, including the role of aPLs, complement system activation, and endothelial cell dysfunction in developing thrombosis. It also outlines the clinical manifestations of APS, such as venous and arterial thrombosis, pregnancy morbidity, and neurological symptoms, along with the diagnostic criteria based on clinical and laboratory findings. The review delves into its pathogenesis, clinical presentation, and diagnostic challenges in the context of CAPS, emphasizing the need for immediate and intensive therapy to manage this life-threatening condition. Current management strategies for APS, including anticoagulant therapy, immunomodulatory treatments, and specific interventions for pregnancy-related complications, are discussed. The review highlights the importance of a multidisciplinary approach for CAPS, combining anticoagulation, high-dose corticosteroids, plasma exchange, and intravenous immunoglobulin. The review also addresses the prognosis and long-term outcomes for patients with APS and CAPS, underlining the necessity for ongoing monitoring and follow-up to prevent recurrent thrombotic events and manage chronic complications. Finally, future directions in research are explored, focusing on emerging therapies, biomarkers for early diagnosis, and the need for clinical trials to advance the understanding and treatment of these complex syndromes. By enhancing the understanding of APS and CAPS, this review aims to improve diagnosis, treatment, and patient care, ultimately leading to better health outcomes for those affected by these conditions.

What we know and what we don’t know about catastrophic antiphospholipid syndrome

Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry"

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): lessons from the "CAPS Registry"

Catastrophic antiphospholipid syndrome: a case report and literature review

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Dramatic devastative complications in a patient with catastrophic antiphospholipid syndrome: A Case report and literature review

Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition

A Case of Catastrophic Antiphospholipid Syndrome with Acute Multiorgan Thrombosis and Concerns for Re-Emergence

Antiphospholipid Syndrome and Catastrophic Antiphospholipid Syndrome: A Comprehensive Review of Pathogenesis, Clinical Features, and Management Strategies

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases

Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed

Catastrophic Antiphospholipid Syndrome in a Lupus Patient With Severe Recurrent Life-Threatening Clinical Manifestations

Catastrophic Antiphospholid Syndrome - An Unusual Case Report

Catastrophic antiphospholipid syndrome and pregnancy. Clinical report

Eculizumab therapy and complement regulation in a case of resistant catastrophic antiphospholipid syndrome

Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?

Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome

Management of Anticoagulation and Antifibrinolytics in Catastrophic Antiphospholipid Syndrome

Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report